Subgroup analysis showed highly significant differences in the group with worse vision.
← all excerpts
Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges.
1
—
—
Subgroup analysis showed highly significant differences in the group with worse vision.